Exercise-Induced Ventricular Tachycardia Unmasking High-Risk Anomalous Right Coronary Artery in an Adult
Abstract
Background: Anomalous aortic origin of a coronary artery (AAOCA) is a rare congenital anomaly associated with myocardial ischemia, ventricular arrhythmias, and sudden cardiac death. Although typically identified in younger individuals, it may present in adulthood with nonspecific or exercise-related symptoms.
Case summary: A 43-year-old physically active man with no prior cardiac symptoms presented with intermittent dizziness and palpitations. Exercise stress testing demonstrated frequent ventricular ectopy progressing to nonsustained ventricular tachycardia during recovery. Coronary computed tomography angiography (CCTA) revealed an anomalous right coronary artery arising from the left sinotubular junction with an interarterial and intramural course. He underwent surgical unroofing with resolution of symptoms on follow-up.
Discussion: AAOCA should be considered in adults presenting with exercise-related ventricular arrhythmias, particularly during stress test recovery. Prompt anatomical evaluation with CCTA enables early identification of high-risk anatomy and timely surgical intervention with favorable outcomes.
Take-home messages: AAOCA can present in adulthood with exercise-related ventricular arrhythmia despite normal cardiac structure. CCTA is essential for identifying high-risk anatomical features, while management decisions should integrate both anatomy and clinical evidence of ischemia or arrhythmia.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol
- Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance
- SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism
- Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors
- Sodium-glucose cotransporter inhibitors: beyond glycaemic control
- Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.